|Day's Range||224.430 - 225.310|
|52 Week Range||184.500 - 261.270|
|PE Ratio (TTM)||7.00|
|Dividend & Yield||2.80 (1.27%)|
|1y Target Est||N/A|
Biotech M&A deals are often driven by the buyer's interest in the lead asset in the biotech's portfolio. In order to capture the full value, spin-outs of the secondary assets following an acquisition can be solution. Several recent examples hare explored.
Here's what I'm trading today amid the 'flat with a positive tone' action.
Here are the three CEOs who got the biggest pay raises last year, and the deepest pay cuts, as calculated by The Associated Press and Equilar, an executive data firm. ___ Top raises: ___ 1. Hock Tan Broadcom ...